Daily Stock List
Homeland Resources Ltd. (HMLA)
Real Pennies and Wallstreetlivechat reported earlier on Homeland Resources Ltd. (HMLA), and we report on the Company today, here at the QualityStocks Daily Newsletter.
Based in Albuquerque, New Mexico, Homeland Resources Ltd. is an emerging oil and gas production and exploration company. It is centering on developing relatively low-risk U.S. natural gas reserves. Among its projects is a large multi-well program based in south-central Oklahoma. Homeland Resources is now focusing on its Liberty Ridge Project in Oklahoma. The Liberty Ridge Project is a multi-well, multi-phase exploration drill program.
The Company is concentrating on the continued expansion of its current production capacity and the development of a new multi-year and multi-well drill program at Liberty Ridge. In addition, it is looking to expand its portfolio to include additional interests in North America.
Furthermore, Homeland Resources has working interests (WIs) in the Smoky Hill Project in Oklahoma. It is presently producing oil from three wells at Smokey Hill. The Smoky Hill Production Program is in south-central Oklahoma. It involves three wells, which are the Marshall, the Bradley, and the Patton. These are Basal Oil Creek Sand targets. One has a second Bromide Sand goal. Expected total program reserves to be developed in this project could be in the range of 750,000 BO and 0.15 BCFG.
Homeland Resources’ Liberty Ridge program is currently being conducted by Homeland Resources and its partners. Homeland and its partners completed a 3-Dimensional (3D) seismic shoot. The resulting data has provided many high-grade targets for drilling this year. The expectation is that drilling at the Liberty Ridge project will continue throughout this year.
Homeland Resources announced this past May that it began a process to review its existing business plan and to identify, examine and consider all strategies available to the Company, near and long term, to carefully determine the optimal course of action for the Company.
The nominal success Homeland and its partners have realized through participation in the drilling program at the Liberty Ridge Oil and Gas Project has prompted this review. In the interim, Homeland management will continue to evaluate all transactions, opportunities, and activities regarding its existing oil and gas assets and commitments.
Yesterday, the directors of Homeland Resources issued an update. Homeland has identified, and is now negotiating to purchase up to 100 percent of TeleSecurity Sciences, Inc. TeleSecurity a privately-held corporation based in Las Vegas, Nevada. Under the terms of the proposed acquisition, Homeland Resources would acquire up to 50 percent of TeleSecurity Sciences by way of equity purchases totaling up to $15,000,000 to fund development of the imaging products of TeleSecurity Sciences. Upon completion of the entire funding, Homeland would acquire the balance of TeleSecurity Sciences via merger. TeleSecurity Sciences is a leader in the development of advanced imaging solutions for medical and security imaging devices and systems.
Homeland Resources Ltd. (HMLA), closed Tuesday's trading session at $0.07, up 2.19%, on 153,473 volume with 18 trades. The average volume for the last 60 days is 103,967 and the stock's 52-week low/high is $0.005/$0.11.
Quadrant 4 Systems Corp. (QFOR)
PennyStocks24 and RedChip reported earlier on Quadrant 4 Systems Corp. (QFOR), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
A Vertical Cloud Platform company, Quadrant 4 Systems Corp. is a foremost Platform-as-a-Service (PaaS) and Software-as-a-Service (SaaS) company. It develops, implements, and operates PaaS and SaaS systems, including qHIX for the health insurance markets; qBLITZ for the digital media business; and qSKU for retailers. Quadrant 4 Systems lists on the OTC Markets’ OTCQB. The Company has its headquarters in Rolling Meadows, Illinois.
The above-mentioned platforms have a built in proprietary set of SMAC (social media, mobility, analytics and cloud computing) components and center on providing solutions for Fortune 500 companies. The engineering of the Company’s PaaS solutions are for Internet scale traffic and built on this Social/Mobile/Analytics/Cloud (SMAC) architecture.
Quadrant 4 Systems’ platforms have a rich set of features and functionality. These include Responsive design, Mobility(Android iOS), Big Data Analytics(Hadoop based), NoSQL, Private-Public Cloud bursting, Security/Authentication/Single Sign-On, Social Modules(Social Graphs, Messaging, Gamification), Engagement(QR Codes, NFC, Beacons, Internet of Things Sensors), among many more.
Last week, Quadrant 4 reported its financial results for Q2 2014. Q2 2014 financial highlights include revenue increasing 31 percent year-over-year to $11.9 million. Gross profit increased 28 percent year-over-year to $3.1 million and gross margin percentage improved to 26 percent from 25 percent in Q1. Moreover, EBITDA for Q2 was $1.7 million and net income improved year-over-year to $23,530 from a net loss of $1.5 million.
In addition, last week, Quadrant 4 System announced that one of the largest insurance marketing organizations in Indiana, JA Benefits, LLC, selected the Company to develop its group and individual healthcare exchanges. A key driver behind JA Benefits selection of Quadrant 4 was the Company's recent U.S. Federally Facilitated Exchange Web Broker Entity (WBE) Agreement with the Centers for Medicare & Medicaid Services (CMS). It provides critical access to data, which permits employees to quickly and easily determine eligibility status and enroll in government funded healthcare options.
Quadrant 4's proprietary Payment Gateway was also a critical element behind JA Benefits decision to adopt Quadrant 4's healthcare exchange technology. Quadrant 4’s Payment Gateway enables payroll deduction and direct pay capabilities.
Quadrant 4 Systems Corp. (QFOR), closed Tuesday's trading session at $0.5757, up 1.00%, on 150,486 volume with 72 trades. The average volume for the last 60 days is 100,819 and the stock's 52-week low/high is $0.066/$1.38.
Health Discovery Corp. (HDVY)
TopPennyStockMover reported recently on Health Discovery Corp. (HDVY), and we are highlighting the Company today, here at the QualityStocks Daily Newsletter.
Health Discovery Corp. is a pattern recognition company headquartered in Atlanta, Georgia. The Company uses advanced mathematical techniques to analyze large amounts of data to uncover patterns that might otherwise be undetectable. It operates primarily in the field of molecular diagnostics where such tools are essential to scientific discovery. Artificial intelligence (AI) and machine learning are terms sometimes used to describe pattern recognition tools. Health Discovery lists on the OTC Markets’ OTCQB.
Health Discovery’s main asset is its intellectual property (IP) that includes advanced mathematical algorithms called Support Vector Machines (SVM) and Support Vector Machines along with Recursive Feature Elimination (SVM-RFE), as well as biomarkers that it discovered through applying its SVM and SVM-RFE techniques to complex genetic and proteomic data. Biomarkers are biological indicators or genetic expression signatures of certain disease states. The Company’s IP is protected by many patents that have been issued or are currently pending worldwide.
Health Discovery’s corporate mission is to use its patents, intellectual expertise, and clinical partnerships chiefly to identify patterns that can advance the science of medicine, and to advance the effective use of its technology in other varied business disciplines. These include the high-tech, financial, as well as healthcare technology markets.
Vladimir Vapnik invented the SVM. It was refined into a more practical application by Isabelle Guyon. Both Mathematicians have provided major contributions to Health Discovery. It was Dr. Guyon's work for the Company that led to the discovery of genes associated with prostate cancer and a diagnostic test. Health Discovery invented some of the earliest SVM's, which are part of its patents. In addition, it has the first patent related to SVM-RFE (recursive feature elimination) in the world.
Health Discovery’s SVM technology outperforms even advanced statistical modeling methodologies including neural networks. SVMs can process infinite amounts of data and analyze the data to find separations and delineations high dimensionality. The Company markets its technology and related developmental expertise to prospects in the healthcare, biotech, and life sciences industries.
Currently, Health Discovery’s commercialization efforts include utilization of its discoveries and knowledge to help develop diagnostic and prognostic predictive tests; licensing of the SVM and SVM-RFE technologies directly to diagnostic companies; and, the potential formation of new ventures with domain experts in other fields where Health Discovery’s pattern recognition technology holds commercial promise.
Health Discovery Corp. (HDVY), closed Tuesday's trading session at $0.0225, down 2.17%, on 118,900 volume with 4 trades. The average volume for the last 60 days is 165,922 and the stock's 52-week low/high is $0.0071/$0.0395.
Hybrid Coating Technologies, Inc. (HCTI)
PennyStocks24, StockMarketQuote.us, PennyStockPlayers, PennyStockClub, The Stock Scout, Penny Stock Pros, Penny Stock Circle, 1-2-3 Stock Alerts, and Stock Twiter reported earlier on Hybrid Coating Technologies, Inc. (HCTI), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.
Hybrid Coating Technologies, Inc. concentrates on improving the quality and safety of coatings and paint for industrial and commercial customers around the world. It is the exclusive licensee of Green Polyurethane™ coatings and paint. Green Polyurethane™ is also referred to as "HNIPU" - hybrid non-isocyanate polyurethane. It is a "hybrid" material, which combines the high chemical resistance properties of epoxy and advanced durability and wear resistance properties of polyurethane. Hybrid Coating Technologies is based in San Francisco, California and the Company lists on the OTCQB.
Green Polyurethane™ coatings and paint are the world's first-ever patent-protected polyurethane-based coatings and paint products that eliminate toxic isocyanates from the whole production process (licensed by Nanotech Industries, Inc.). Green Polyurethane™ can be applied in one coating in most cases. Furthermore, it provides the first sound solution to the environmental and health hazards associated with isocyanates in polyurethane. Green Polyurethane™ safety features allow it to be applied without the interruption of business due to public exposure. This creates an additional 30-60 percent savings on application costs for customers.
Hybrid Coating Technologies has expanded its technology with a new UV curing formulation. The Company’s new formulation is the only non isocyanate UV curing polyurethane formulation in the world. This new formulation allows its floor coating products to fully cure within an hour instead of seven days which is the normal industry standard.
Hybrid Coating Technologies’ world renowned head scientist is Dr. Oleg Figovsky. Dr. Figovsky is one of the most well-recognized and accomplished scientists and inventors in the nanotech field. He is the principal inventor of the Green Polyurethane™ platform technology. Dr. Figovsky has more than 40 years of experience in the field of special coatings, adhesives, sealants, and corrosion protection.
Last month, Hybrid Coating Technologies announced that it is entering into the global wood protection coatings market. Its new patent allows for a major increase in the product's elongation characteristics of up to 300 percent while maintaining the same high quality mechanical and chemical resistant properties its products have a reputation for.
Mr. Joseph Kristul, Hybrid’s President/CEO, said, "We are very pleased to have yet another patent filed as we continue to increase our IP portfolio and broaden our reach by adding new verticals that we can service in the polyurethane industry."
Hybrid Coating Technologies, Inc. (HCTI), closed Tuesday's trading session at $0.1579, up 9.27%, on 853,170 volume with 83 trades. The average volume for the last 60 days is 100,316 and the stock's 52-week low/high is $0.0736/$0.80.
Maverick Minerals Corp. (MVRM)
StreetAuthority Daily, TopStockAnalysts, and Dividend Opportunities reported earlier on Maverick Minerals Corp. (MVRM), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Maverick Minerals Corp. is an exploration stage company involved in the acquisition, exploration, and development of prospective oil and gas properties and mineral properties. As of August 20, 2012, Maverick Minerals operates as a subsidiary of Energold Minerals, Inc. Energold holds a 100 percent undivided right, title, and interest in a group of mining claims located in Thunder Bay, Ontario, called the Jarvis Island Property. Incorporated in 1998, Maverick Minerals is based in Toronto, Ontario.
With the terms of the Agreement, as amended, Energold granted Maverick Minerals the right, in the form of two options, to acquire an aggregate 51 percent working interest (WI) in the Jarvis Property, subject to certain conditions. This includes the issuance of up to 400,000 shares of Maverick common stock and incurring $400,000 in exploration expenditures on or before June 30, 2018.
Regarding the Jarvis Island Property, Jarvis Island consists largely of diabase and argillites. A vein 10 to 15 ft. in width of calcite, quartz and barite cuts across the eastern end of the island with a north-south orientation with a clip of 50 to the east. The Island is approximately 35 miles south of Thunder Bay, Ontario, approximately 5 km from the shore of Lake Superior near to the U.S. border (Minnesota).
The property has 13.355 hectares or 33 acres and is of rocky terrain. The property is believed to have mineral potential for the production of barite. Barite or barium sulphate is a stabilizing agent utilized in the drilling of oil and gas wells. Preliminary work to establish access to the island from Thunder Bay to deploy geological contractors to retrieve ground samples was undertaken in the third quarter of 2013.
Maverick Minerals is reviewing mineral resource opportunities in Ontario and Quebec. These exploration properties are targets for base metals, gold and silver. Further properties, located in Utah and Idaho, are in different stages of due diligence.
Maverick continues to keep a few small oil and gas leases in south-central Texas. The Company has no plans to invest further resources in oil and gas exploration in Texas on its own properties. However, it will continue to assess possible projects in oil and gas to leverage the experience gained over the past several years in other drilling and production.
Maverick Minerals Corp. (MVRM), closed Tuesday's trading session at $0.44, up 10.00%, on 40,572 volume with 34 trades. The average volume for the last 60 days is 6,554 and the stock's 52-week low/high is $0.03/$3.55.
VistaGen Therapeutics, Inc. (VSTAD)
The QualityStocks Daily Newsletter would like to spotlight VistaGen Therapeutics, Inc. (VSTAD). Today, VistaGen Therapeutics, Inc. closed trading at $15.00, even with yesterday's close. The stock’s average daily volume over the past 60 days is 305, and its 52-week low/high is $5.00/$17.80.
VistaGen Therapeutics Inc. today announced that the Canadian Intellectual Property Office has issued a Notice of Allowance for Canadian Patent Application No. 2,487,058, entitled "Mesoderm and Definitive Endoderm Cell Populations." This patent, which is licensed exclusively to VistaGen by the Icahn School of Medicine at Mount Sinai in New York, will further expand VistaGen's intellectual property portfolio for pluripotent stem cell culture systems that produce human cells of the endoderm lineage, including liver, lung, pancreas, parathyroid and thyroid cells.
VistaGen Therapeutics, Inc. (VSTAD) is a biotechnology company applying stem cell technology for drug rescue and cell therapy. Drug rescue combines human stem cell technology with modern medicinal chemistry to generate new chemical variants ("drug rescue variants") of once-promising drug candidates that have been discontinued during late-stage preclinical development due to heart or liver safety concerns. VistaGen also focuses on cell therapy, or regenerative medicine, which includes repairing, replacing or restoring damaged tissues or organs
VistaGen's versatile stem cell technology platform, Human Clinical Trials in a Test Tube™, has been developed to provide clinically relevant predictions of potential heart and liver toxicity of promising new drug candidates long before they are ever tested on humans.
By more closely approximating human biology than conventional animal studies and other nonclinical techniques and technologies currently used in drug development, VistaGen's human stem cell-based bioassay systems can improve the predictability of the drug development cycle and lower the cost of new drug research and development by identifying product failures earlier in the cost curve. According to the Food and Drug Administration even only a ten percent improvement in predicting failure before clinical trials could save $100 million in development costs, which savings ultimately could be passed on to patients.
Using mature human heart cells produced from stem cells, VistaGen has developed and internally validated CardioSafe 3D™, a novel three-dimensional (3D) bioassay system for predicting the in vivo cardiac effects of new drug candidates before they are tested in humans. VistaGen is now focused on using CardioSafe 3D™ to generate up to two new, safer small molecule drug rescue variants every twelve to eighteen months. VistaGen anticipates that these drug rescue variants will be modified versions of once-promising new drug candidates that have been discontinued by pharmaceutical companies and academic research institutions because of heart toxicity concerns, despite substantial prior investment and positive efficacy data demonstrating their potential therapeutic and commercial benefits. In most cases, VistaGen plans to license or sell its new, safer drug rescue variants in strategic partnering arrangements with global pharmaceutical companies, arrangements providing VistaGen with both near term and downstream milestone payments and economic participation rights but without future development cost obligations.
AV-101, VistaGen's lead small molecule prodrug candidate, has successfully completed Phase I clinical development in the U.S. for treatment of neuropathic pain, a serious and chronic condition affecting millions of people worldwide, depression, and other neurological diseases and conditions. To date, the U.S. National Institutes of Health (NIH) has awarded VistaGen over $8.75 million for development of AV-101. Management anticipates strategically out-licensing AV-101 to a development and marketing partner in 2013.
VistaGen is also developing LiverSafe 3D™, a novel predictive liver toxicity and drug metabolism bioassay system for drug rescue applications. In parallel with drug rescue activities, the Company is funding early-stage nonclinical studies focused on potential cell therapy applications of its Human Clinical Trials in a Test Tube™ platform. Disclaimer
VistaGen Therapeutics, Inc. Company Blog
VistaGen Therapeutics, Inc. News:
UPDATE: VistaGen Receives Notice of Allowance for Canadian Patent Further Expanding Stem Cell Technology Platform
VistaGen Announces Reverse Stock Split
VistaGen Receives Notice of Allowance for Canadian Patent Expanding Stem Cell Technology Platform
Oriens Travel and Hotel Management Corp. (OTHM)
The QualityStocks Daily Newsletter would like to spotlight Oriens Travel and Hotel Management Corp. (OTHM). Today, Oriens Travel and Hotel Management Corp. closed trading at $0.0003, on 18,903,500 volume with 21 trades. The stock’s average daily volume over the past 60 days is 32,823,518, and its 52-week low/high is $0.0002/$0.0024.
Oriens Travel and Hotel Management Corp. announced today, that Ken Chua, President of Oriens Travel & Hotel Management, along with the Company's executives and consultants (Domestic and Costa Rican), are in Costa Rica completing pending acquisitions; primarily initiating the formal transfer of assets. Mr. Chua noted, "The timelines of the formal transfer is very definitive. We expect to be able to lawfully make this announcement after Labor Day."
Oriens Travel and Hotel Management Corp. (OTHM) is a provider of proprietary technology, marketing solutions, infrastructure and branding services to hotel operators.
The company's innovative platform functions as a powerful vehicle to help hotel operators achieve greater success in three specific areas: (i) expanded international exposure and recognition, (ii) powerful core structure, and (iii) high occupancy rates that drive increases in bottom-line profits. Oriens continuously refines its suite of proprietary solutions to deliver measurable and proven results to hotel properties. This success has been reflected in those properties operating under the Hotel PURE brand as well as with independent boutique hotel properties utilizing the company's Friendly Reservation Online (FROL) booking engine technology and internet marketing services.
Operating a successful bi-lateral business model, Oriens has four objectives:
1. To franchise the Hotel PURE brand to selected hotel properties worldwide similar to the business model currently employed by Big Brand operators such as Holiday Inn, Marriott, Sheraton and others;
2. Provide highly efficient and economical back-end booking engine technology services to independently branded boutique hotels that require a robust online presence;
3. Launch a stand-alone online hotel booking search engine primarily focused on Central America; and,
4. Expand the portfolio of Oriens-owned boutique hotels operating under the Hotel PURE brand.
The company initially began growing its operations primarily in the United States. However most recently, major opportunities in Central America began presenting themselves, giving Oriens the ability to retool its business model. Now the company is positioned to acquire, own and operate its own properties – which would be marketed under the new brand with occupancies handled by the re-launched online booking engine system.
Ultimately, Oriens intends to become a top-tier hotel brand operator and Internet booking and marketing service provider, qualifying as a preferred supplier to lending institutions. The company also intends to establish an invaluable international footprint with its online booking engine technology and marketing offerings; making that segment of its business a prime acquisition target for major online travel search and booking engine companies. Advancement toward this goal is guided by an executive management team with deep expertise in technology, banking, management, hospitality, branding and marketing, technical development and more. Disclaimer
Oriens Travel and Hotel Management Corp. Company Blog
Oriens Travel and Hotel Management Corp. News:
Oriens Provides Update on Finalization of Acquisition; Closing & Transfer of Asset
Oriens to Up-List
Oriens Engages PCAOB Auditor
NutraNomics, Inc. (NNRX)
The QualityStocks Daily Newsletter would like to spotlight NutraNomics, Inc. (NNRX). Today, NutraNomics, Inc. closed trading at $0.0693, up 6.29%, on 23,825 volume with 6 trades. The stock’s average daily volume over the past 60 days is 22,640, and its 52-week low/high is $0.06/$1.48.
NutraNomics, Inc. (NNRX) is focused on the research and development of nutritional dietary supplements, skin and body care products and transdermal patches. In addition to creating formulas for hundreds of companies, the company has produced and branded its own product lines which are sold through retail and wholesale channels. Additionally the company private labels and does custom manufacturing for several supplement companies in national and international markets.
Nearly all vitamins currently on the market are isolated and/or synthetic. The human body doesn’t recognize these types of vitamins and as a result cannot absorb them because they are either missing critical nutritional components or are not food based. NutraNomics has rapidly grown its business over the past 18 years by offering superior food and plant-based products blended from the highest quality sources available for maximum bioavailability.
Today NutraNomics has sales teams in seven different countries promoting its diversified line of wholefood-based supplements, specialty formulas, and remedies. All facilities used to produce the gluten-free, non-GMO nutritional products are cGMP Compliant and FDA approved. To ensure the highest purity potency and quality, the company takes it another step forward by performing additional content testing on all raw materials used to manufacture its products.
NutraNomics is more than just a health supplement provider. As a company dedicated to supporting the worldwide community of people who want to live healthy, NutraNomics is making an impact on those who are suffering from various types of diseases that need specialized diet to enhance their lifestyle. To fulfill this mission NutraNomics has invested in clinical studies for controlling diabetes, heart disease and cancer with dietary supplements. Strong growth is anticipated to continue as the company continues to introduce cutting-edge products and taps into new markets. Disclaimer
NutraNomics, Inc. Company Blog
NutraNomics, Inc. News:
Nutranomics Whole Food Based Vitamins and Supplements Reports Increase in Wholesale & Retail Sales
Nutranomics Whole Food Based Vitamins and Supplements Available on Amazon.com
Nutranomics Whole Food Based Vitamins and Supplements Joins Forces With Stonegate
Panther Energy, Inc. (PNEG)
The QualityStocks Daily Newsletter would like to spotlight Panther Energy, Inc. (PNEG). Today, Panther Energy, Inc. closed trading at $0.0369, up 5.43%, on 6,350 volume with 2 trades. The stock’s average daily volume over the past 60 days is 10,258, and its 52-week low/high is $0.0005/$0.095.
Panther Energy, Inc. (PNEG) is a development stage oil and gas exploration and production company focused on developing properties in North America. The company plans to minimize the risk of exploration through development of proved petroleum reserves, and expects to maximize profit through strategic acquisition and liquidation of selected oil and gas properties.
The company specializes in acquiring low risk, high upside properties with substantial exploration potential. Through improvements in oil and gas production technologies, Panther Energy aims to rapidly increase production levels and generate predictable, sustainable value. The business strategy utilized calls for both 100% acquisitions and joint-ventures to maximize production capacity.
Evergreen Petroleum, a joint venture partner, is working closely with the company to explore oil-bearing formations in Wyoming. Evergreen has conducted and will continue to conduct both regional and local geological studies to define prospects that are worthy of acquiring oil and gas leases. By partnering with industry experts such as Evergreen, Panther Energy has strategically added extensive technical guidance and field management experience.
Even during challenging times, the world depends on oil & gas exploration and production companies to deliver millions of barrels of oil every day. Increased demand from emerging countries such as China further escalates competition for this precious resource. Backed by an experienced group of professionals, Panther Energy is well positioned to generate substantial revenues in the short and long term future. Disclaimer
Panther Energy, Inc. Company Blog
Panther Energy, Inc. News:
Panther Energy Changes Ticker Symbol and Provides Corporate Update
Innocent Inc. Announces Name Change to Panther Energy
Innocent Inc. Appoints Peter Kent to Advisory Council
Armco Metals Holdings, Inc. (AMCO)
The QualityStocks Daily Newsletter would like to spotlight Armco Metals Holdings, Inc. (AMCO). Today, Armco Metals Holdings, Inc. closed trading at $0.1969, up 3.80%, on 102,416 volume with 187 trades. The stock’s average daily volume over the past 60 days is 510,242, and its 52-week low/high is $0.159/$0.58.
Armco Metals Holdings, Inc. (AMCO), since its founding 10 years ago, has tirelessly worked to create low-cost, high-quality solutions to meet steel industry demands and achieve its goal to become the largest scrap steel recycler in China. The company operates through five subsidiaries located in key regions throughout the country to source, import, process, and distribute quality, environmentally friendly recycled scrap steel, as well as metal and non-ferrous metal ore.
Subsidiaries Armco Metals International, Ltd., Armco (Lianyungang) Renewable Metals, Inc., Armet (Lianyungang) Holdings, Inc., Henan Armco & Metawise Trading Co., Ltd., Armco Metals (Shanghai) Holding, Ltd. support Armco Metal’s overarching corporate mission and operate to provide the country’s steel production industry with sustainable, responsible solutions to its material needs. Aligned with China’s green initiatives, Armco Metals and its subsidiaries are helping the government reach its scrap metal consumption goal of 20% by 2015.
Leveraging long-standing relationships with more than 10 international metal suppliers, more than 100 small- and medium-sized Chinese steel production companies, and some of the country’s large state-run foundries, Armco Metals benefits from a steady and dependable supply of demand for the company’s high-quality product known for excellent market values.
Armco Metals’ management team has established a unique approach to business and environment by providing responsible solutions based on environmentally friendly practices; reliable, cost-effective sourcing; and quality metal products. Backed by more than 10 years of industry experience, company executives have successfully positioned the company as credible, dependable partner for customers, suppliers, and investors within the steel production market. Disclaimer
Armco Metals Holdings, Inc. Company Blog
Armco Metals Holdings, Inc. News:
China's Ministry of Industry and Information Technology Approves Subsidiary
Armco Metals Holdings, Inc. Receives Government Approval to Import 20,000 Metric Tons of Restricted Materials Annually
Armco Metals Holdings, Inc. Receives $15 Million Credit Approval From a Chinese Commercial Bank
Today's Top 3
Mega Penny Stock Pick
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Alliance Creative Group (ACGX) COO Featured in Exclusive QualityStocks Interview
- Armco Metals Holdings, Inc. (AMCO) China's Ministry of Industry and Information Technology Approves Subsidiary
- Big Tree Group, Inc. (BIGG) Launches New Domestic Online Ecommerce Platform
- Consorteum Holdings, Inc. (CSRH) Signs Mobile Application Development Contract With Bet Butler Limited
- eCrypt Technologies, Inc. (ECRY) and Whitenoise Laboratories Canada Inc. (WNL) Enter Into a Strategic Marketing Alliance
- Infinite Group, Inc. (IMCI) Announces Exclusive Government Channel Partner Agreement for Content Management Tools
- LD Holdings, Inc. (LDHL) Signs Joint Venture With Internet Marketing Consortium (IMC)
- Mabwe Minerals Inc. (MBMI) Raptor Resources Holdings Issues Update on the Derbyshire Stone Quarry
- Mobile Lads Corp. (MOBO) Signs Reseller Agreement With Smart Mobile Rewards
- NutraNomics, Inc. (NNRX) Whole Food Based Vitamins and Supplements Available on Amazon.com
- One World Holdings, Inc. (OWOO) One World Doll Project Announces New Online Distribution With Toys"R"UsŪ
- Oriens Travel and Hotel Management Corp. (OTHM) Prepares for Debut of Refreshed Brand
- P2 Solar, Inc. (PTOS) Signs a 35 year Power Purchase Agreement
- Pan Global Corp. (PGLO) Comments on Industry Report That the India Renewable Energy Market Opportunity Is Worth USD $10.5 Billion by 2017
- Panther Energy, Inc. (PNEG) Announces Name Change to Panther Energy
- Raptor Resources Holdings Inc. (RRHI) Issues Update on the Derbyshire Stone Quarry
- VistaGen Therapeutics, Inc. (VSTAD) Announces Reverse Stock Split
- Well Power Inc. (WPWR) to host second webinar on proprietory micro-refinery technology
- WordLogic Corp. (WLGC) the Sale of Exclusive Rights to Legal Enterprise Solutions to Private Equity Group
- Zenosense, Inc. (ZENO) Begins Development of Lung Cancer Detection Device